Ask AI
ProCE Banner Activity

TROP-2–Directed ADCs in TNBC: Foundations and Rationale

Slideset

Review key slides on TROP-2 biology, ADC design, bystander effect, toxicity considerations, and multidisciplinary planning for TROP-2–directed ADCs in metastatic TNBC.

Released: July 10, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Target Audience

This activity has been designed to meet the educational needs of oncologists and other healthcare professionals involved in the management of patients with triple-negative breast cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Understand the significance of TROP-2 expression in TNBC and its association with disease progression and prognosis